Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2007-9-26
pubmed:abstractText
Anti-cyclic citrullinated peptide (anti-CCP) antibodies are a stronger predictor of the severity of rheumatoid arthritis than is rheumatoid factor (RF). Their role in predicting outcome in unselected patients with new-onset inflammatory polyarthritis (IP) has not been examined. The aims of this study were to examine the role of baseline RF and anti-CCP antibodies in determining the likelihood of patients having erosions at presentation or in predicting future radiologic damage, and to determine whether anti-CCP antibodies or RF is sufficiently robust to be clinically useful in guiding treatment decisions in early IP.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-10524690, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-10643712, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-10943873, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-11953966, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-12435162, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-12525380, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-12528102, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-12709545, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-1273600, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-14872482, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-14969058, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-15547083, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-15621577, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-16176994, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-16207336, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-16287917, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-16469118, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-16606649, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-16670828, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-16817941, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-16859535, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-2369420, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-2645876, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-3358796, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-3423750, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-3708236, http://linkedlifedata.com/resource/pubmed/commentcorrection/17763407-920239
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0004-3591
pubmed:author
pubmed:issnType
Print
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2929-35
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register.
pubmed:affiliation
University of Manchester, Manchester, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't